• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[美西律治疗预激综合征伴心房颤动]

[Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome].

作者信息

Róna G

出版信息

Z Gesamte Inn Med. 1986 Jun 15;41(12):355-8.

PMID:3765734
Abstract

It is reported on 6 patients with Wolff-Parkinson-White syndrome in whom spontaneously appeared auricular fibrillation with high ventricular frequency. By the intravenous administration of mexiletine in three patients the sinus rhythm could be restored. In two patients at first only a reduction of the tachycardia and a disappearing of the QRS-broadening took place; the additional administration of quinidine then led to the return of the sinus rhythm. In one patient, despite combined treatment, the return of sinus rhythm could not be achieved, mexiletine, however, led at once to the decrease of the ventricular rate, to the normalisation of the QRS-duration and to the disappearance of all signs of congestive heart failure. The therapeutic mechanism of mexiletine in the Wolff-Parkinson-White syndrome is discussed and it administration for the treatment of the cases complicated by auricular fibrillation is recommended.

摘要

据报道,6例预激综合征患者自发出现心房颤动且心室率快。3例患者静脉注射美西律后可恢复窦性心律。2例患者起初仅心动过速减轻且QRS波增宽消失;随后加用奎尼丁使窦性心律恢复。1例患者尽管联合治疗仍未恢复窦性心律,但美西律立即使心室率减慢、QRS时限正常化且所有充血性心力衰竭体征消失。文中讨论了美西律在预激综合征中的治疗机制,并推荐其用于治疗并发心房颤动的病例。

相似文献

1
[Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome].[美西律治疗预激综合征伴心房颤动]
Z Gesamte Inn Med. 1986 Jun 15;41(12):355-8.
2
[Is the transesophageal approach preferable to endocavitary approach in the evaluation of Wolff-Parkinson-White syndrome?].
Arch Mal Coeur Vaiss. 1995 Mar;88(3):353-8.
3
[Atrial fibrillation induced by massage of the carotid sinus in patients with orthodromic reciprocal supraventricular tachycardia and Wolff-Parkinson-White syndrome].[按摩颈动脉窦诱发房室折返性室上性心动过速和预激综合征患者房颤]
Minerva Cardioangiol. 1995 Jan-Feb;43(1-2):55-9.
4
[Effects of mexiletine in the Wolff-Parkinson-White syndrome].美西律对预激综合征的作用
Arch Mal Coeur Vaiss. 1981 Nov;74(11):1315-23.
5
Amiodarone in long term management of refractory cardiac tachyarrhythmias.胺碘酮用于难治性心脏快速性心律失常的长期管理。
N Z Med J. 1981 Jan 28;93(676):31-5.
6
[Lidocaine administration in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation (author's transl)].[利多卡因用于预激综合征合并心房颤动患者(作者译)]
G Ital Cardiol. 1979;9(4):428-33.
7
[High frequency catheter ablation of left-sided manifest accessory conduction pathways during sinus rhythm and in continuous atrial fibrillation].[窦性心律及持续性心房颤动时左侧显性旁道的高频导管消融]
Z Kardiol. 1994;83 Suppl 5:121-5.
8
Atrial fibrillation with wide QRS tachycardia and undiagnosed Wolff-Parkinson-White syndrome: diagnostic and therapeutic dilemmas in a pediatric patient.伴有宽QRS波心动过速的心房颤动及未确诊的预激综合征:一名儿科患者的诊断与治疗困境
Pediatr Emerg Care. 2012 Nov;28(11):1227-9. doi: 10.1097/PEC.0b013e31827208c5.
9
[Malignant ventricular tachyarrythmia due to atrial fibrillation in the Wolff-Parkinson-White syndrome. Section of the Kent bundle apropos of 2 cases].[预激综合征中房颤所致恶性室性心律失常。关于2例病例的肯特束切断术]
Arch Mal Coeur Vaiss. 1981 Jul;74(7):829-36.
10
[Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].美西律对室上性心律失常、预激综合征及持续性反复性室性心动过速的抗心律失常疗效。关于这些较少被关注的治疗效果的思考
Clin Ter. 1984 Feb 15;108(3):199-208.

引用本文的文献

1
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.美西律。对其药效学和药代动力学特性以及在心律失常治疗中的治疗用途的综述。
Drugs. 1990 Sep;40(3):374-411. doi: 10.2165/00003495-199040030-00005.